MOSCOW, May 7. /TASS/. Around 500,000 doses of the EpiVacCorona Covid-19 vaccine have been dispatched to Russian regions, Tatiana Nepomnyashchikh, deputy head of the Vector Center, the vaccine developer, said on Friday.
"Slightly less than half a million doses have been sent to regions," she said in an interview with the Vesti evening news roundup on the Rossiya-1 television channel.
EpiVacCorona was the second coronavirus vaccine to be registered in Russia, on October 14, 2020.
Mass production of the vaccine was launched in mid-spring and some 1.1 million doses were manufactured in April. Production is planned to expand to 5 million doses a month in June. Apart from that, Vector is conducting clinical tests of triple vaccination with the EpiVacCorona vaccine. It is also working on a coronavirus vaccine delivered as nasal drops.